![](/img/cover-not-exists.png)
[BMJ Publishing Group Ltd and European League Against Rheumatism Annual European Congress of Rheumatology, 14–17 June, 2017 - ()] Oral Presentations - OP0131 Optimal dose of tocilizumab for the treatment of giant cell arteritis: efficacy, safety, and exposure-efficacy analysis from giacta
Stone, JH, Tuckwell, K, Dimonaco, S, Klearman, M, Mallalieu, NL, Aringer, M, Blockmans, D, Brouwer, E, Cid, MC, Dasgupta, B, Rech, J, Salvarani, C, Schett, G, Schulze-Koops, H, Spiera, R, Unizony, SH,Language:
english
DOI:
10.1136/annrheumdis-2017-eular.2381
File:
PDF, 168 KB
english